EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sarcopenia in end-stage liver disease and after liver transplantation

S Leunis, M Vandecruys, A H Van Craenenbroeck, V Cornelissen, S Bogaerts, S De Smet, D Monbaliu

Acta Gastro Enterologica Belgica · 2023-06 · 86 (2) · 323-334

DOI: 10.51821/86.2.11412 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Gastro Enterologica Belgica, 2023-06. Verfasst von S Leunis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Transplantation, Abdominal Transplantation, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Sarcopenia, Liver Transplantation, End Stage Liver Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 140 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia occurs in 30-70% of patients with end-stage liver disease and is associated with inferior pre- and post-liver transplant outcomes such as prolonged intubation times, long intensive care and hospitalization times, heightened risk of post-transplant infection, reduced health-related quality of life, and increased rates of mortality. The pathogenesis of sarcopenia is multifactorial and involves biochemical disturbances such as hyperammonemia, low serum concentrations of branched-chain amino acids (BCAAs) and low serum levels of testosterone, as well as chronic inflammation, inadequate nutritional status, and physical inactivity. Prompt recognition and accurate assessment of sarcopenia are critical and require imaging, dynamometry, and physical performance testing for the assessment of its subcomponents: muscle mass, muscle strength, and muscle function, respectively. Liver transplantation mostly fails to reverse sarcopenia in sarcopenic patients. In fact, some patients develop de novo sarcopenia after undergoing liver transplantation. The recommended treatment of sarcopenia is multimodal and includes a combination of exercise therapy and complementary nutritional interventions. Additionally, new pharmacological agents (e.g. myostatin inhibitors, testosterone supplements, and ammonia-lowering therapy) are under investigation in preclinical studies. Here, we present a narrative review of the definition, assessment, and management of sarcopenia in patients with end-stage liver disease prior to and after liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaLiver TransplantationEnd Stage Liver DiseaseHumansQuality of LifeTestosterone

Stichwörter der Autor:innen

Muscle quantity/qualityliver diseasemuscle strengthphysical performance

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Transplantation, Abdominal Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium.
  • Department of Rehabilitation Sciences, Research Group for Rehabilitation in Internal Disorders, KU Leuven, Leuven, Belgium.
  • Department of Development and Regeneration, Locomotor and Neurological Disorders, KU Leuven, Leuven, Belgium.
  • Transplantoux foundation, Leuven, Belgium.

Zitieren

APA

Leunis, S., Vandecruys, M., Van Craenenbroeck, A. H., Cornelissen, V., Bogaerts, S., De Smet, S., & Monbaliu, D. (2023). Sarcopenia in end-stage liver disease and after liver transplantation. Acta Gastro Enterologica Belgica, 86(2), 323-334. https://doi.org/10.51821/86.2.11412

Vancouver

Leunis S, Vandecruys M, Van Craenenbroeck AH, Cornelissen V, Bogaerts S, De Smet S, et al. Sarcopenia in end-stage liver disease and after liver transplantation. Acta Gastro Enterologica Belgica. 2023;86(2):323-334. doi:10.51821/86.2.11412

BibTeX
@article{Leunis2023,
  author = {Leunis, S and Vandecruys, M and Van Craenenbroeck, A H and Cornelissen, V and Bogaerts, S and De Smet, S and Monbaliu, D},
  title = {Sarcopenia in end-stage liver disease and after liver transplantation},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2023},
  volume = {86},
  number = {2},
  pages = {323--334},
  doi = {10.51821/86.2.11412}
}
Kostenlos starten →